Toripalimab Plus Chemotherapy for Patients With Treatment-Naive Advanced Non–Small-Cell Lung Cancer: A Multicenter Randomized Phase III Trial (CHOICE-01)Zhijie Wang, Lei Nie, Yun Fan et al.|Journal of Clinical Oncology|2022Cited by 177
Liver kinase B1/adenosine monophosphate‑activated protein kinase signaling axis induces p21/WAF1 expression in a p53‑dependent mannerQing Ma, Diansheng Zhong|Oncology Letters|2018Cited by 8
Safety and efficacy of aprepitant as mono and combination therapy for the prevention of emetogenic chemotherapy-induced nausea and vomiting: post-marketing surveillance in ChinaYunpeng Yang, Li Zhang, Nong Yang et al.|Chinese Clinical Oncology|2020Cited by 8
Long-term follow-up results from the GLORY study: phase II study of gumarontinib in East Asian patients with MET exon 14 skipping mutated non-small cell lung cancerShun Lü, Yibin Wang, Yongfeng Yu et al.|Translational Lung Cancer Research|2025Cited by 2